ÂÜÀòÂÒÂ×

Mark Sassler is a seasoned professional in the pharmaceutical industry with extensive experience in business development and management. Currently serving as the Business Director for the Ophthalmic Business at Jubilant HollisterStier Contract Manufacturing & Services since December 2018, Mark oversees the manufacturing of various ophthalmic dosage forms. Prior to this role, Mark was a Partner and Executive Global Director of Business Development at Clinpak Technologies from May 2008 to December 2018, focusing on generic and biotechnology pharmaceuticals. Mark also held the position of Director of Business Development at Bilcare Limited, where Mark evaluated the viability of entering the CMO arena, and was the Founder, Board Member, and President of Mid-Atlantic Isotopes, a manufacturer of radiopharmaceuticals. Mark holds a Bachelor of Science degree from Bowling Green State University.